Abivax (ABVX) Net Cash Flow (2024 - 2026)
Abivax's (ABVX) quarterly Net Cash Flow came in at $664983.5 in Q1 2026, up 101.58% year-on-year from $329887.1 in Q1 2025, and up 100.76% quarter-over-quarter from -$87.9 million in Q4 2025.
Abivax (ABVX) Net Cash Flow (2024 - 2026) Analysis & Trends
Abivax's Net Cash Flow history runs 3 years deep, the most recent figure standing at $664983.5 for Q1 2026.
- On a quarterly basis, Net Cash Flow rose 101.58% year-over-year to $664983.5 in Q1 2026; TTM through Mar 2026 was $491.3 million, a 430.49% increase from a year earlier, with the FY2025 full-year figure at $440.0 million, up 469.24% from the prior year.
- Net Cash Flow advanced to $664983.5 in Q1 2026 per ABVX's latest filing, from -$87.9 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $626.0 million in Q3 2025 and bottomed at -$87.9 million in Q4 2025.
- The 3-year median for Net Cash Flow is -$41.4 million (2024), against an average of $36.7 million.
- Biggest YoY gain for Net Cash Flow was 1527.7% in 2025; the steepest drop was 232.67% in 2025.
- Year by year, Net Cash Flow stood at -$41.4 million in 2024, then tumbled by 112.09% to -$87.9 million in 2025, then jumped by 100.76% to $664983.5 in 2026.
- Per Business Quant, the three latest ABVX Net Cash Flow figures stand at $664983.5 (Q1 2026), -$87.9 million (Q4 2025), and $626.0 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 224.46 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 57.19 Mn |
| 10 | Abivax | 9.98 Bn | 9.98 Bn | - | 664,983.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 664,983.53 |
| Mar 31, 2026 | 664,983.53 |
| Dec 31, 2025 | -87.89 Mn |
| Dec 31, 2025 | -87.89 Mn |
| Sep 30, 2025 | 625.98 Mn |
| Sep 30, 2025 | 625.98 Mn |
| Jun 30, 2025 | -47.45 Mn |
| Jun 30, 2025 | -47.45 Mn |
| Mar 31, 2025 | -42.11 Mn |
| Mar 31, 2025 | -42.11 Mn |
| Dec 31, 2024 | -41.44 Mn |
| Dec 31, 2024 | -41.44 Mn |
| Sep 30, 2024 | -43.85 Mn |
| Sep 30, 2024 | -43.85 Mn |
| Jun 30, 2024 | -21.26 Mn |
| Jun 30, 2024 | -21.26 Mn |
| Mar 31, 2024 | -12.66 Mn |
| Mar 31, 2024 | -12.66 Mn |